Cited by 2,805Plant biochemistry and biosynthesisMicrobial Metabolic Engineering and BioproductionFungal and yeast genetics research

Production of the antimalarial drug precursor artemisinic acid in engineered yeast

Ro, Dae-Kyun, Paradise, Eric M., Ouellet, Mario, Fisher, Karl J., Newman, Karyn L., Ndungu, John M., Ho, Kimberly A., Eachus, Rachel A. +7 more·2006·Nature

Abstract

Malaria is a global health problem that threatens 300-500 million people and kills more than one million people annually. Disease control is hampered by the occurrence of multi-drug-resistant strains of the malaria parasite Plasmodium falciparum. Synthetic antimalarial drugs and malarial vaccines are currently being developed, but their efficacy against malaria awaits rigorous clinical testing. Artemisinin, a sesquiterpene lactone endoperoxide extracted from Artemisia annua L (family Asteraceae; commonly known as sweet wormwood), is highly effective against multi-drug-resistant Plasmodium spp., but is in short supply and unaffordable to most malaria sufferers. Although total synthesis of artemisinin is difficult and costly, the semi-synthesis of artemisinin or any derivative from microbially sourced artemisinic acid, its immediate precursor, could be a cost-effective, environmentally friendly, high-quality and reliable source of artemisinin. Here we report the engineering of Saccharomyces cerevisiae to produce high titres (up to 100 mg l(-1)) of artemisinic acid using an engineered mevalonate pathway, amorphadiene synthase, and a novel cytochrome P450 monooxygenase (CYP71AV1) from A. annua that performs a three-step oxidation of amorpha-4,11-diene to artemisinic acid. The synthesized artemisinic acid is transported out and retained on the outside of the engineered yeast, meaning that a simple and inexpensive purification process can be used to obtain the desired product. Although the engineered yeast is already capable of producing artemisinic acid at a significantly higher specific productivity than A. annua, yield optimization and industrial scale-up will be required to raise artemisinic acid production to a level high enough to reduce artemisinin combination therapies to significantly below their current prices.

Integrity signals

Registry

Crossref · 10.1038/nature04640

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ro, D.-K., Paradise, E. M., Ouellet, M., Fisher, K. J., Newman, K. L., Ndungu, J. M., Ho, K. A., Eachus, R. A., Ham, T. S., Kirby, J., Chang, M. C. Y., Withers, S. T., Shiba, Y., Sarpong, R., & Keasling, J. D.
Affiliations
  • QB3 (US)
  • Amyris (United States) (US)
Corresponding author
Keasling, Jay D.
Venue
Nature
Published
2006-04-13
Volume
440
Issue
7086
Pages
940-943
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2149202606
Cited by
2,805
References
25
Citations by year
2026: 86 · 2025: 94 · 2024: 132 · 2023: 115 · 2022: 133 · 2021: 120 · 2020: 151 · 2019: 131 · 2018: 155 · 2017: 153 · 2016: 165 · 2015: 165 · 2014: 190 · 2013: 191 · 2012: 230
FWCI
40.83
Type
journal article
Language
en
Open access
closed
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
Funders
  • National Science Foundation
  • U.S. Department of Agriculture
  • Bill and Melinda Gates Foundation
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Plant biochemistry and biosynthesis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial Metabolic Engineering and Bioproduction
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Keywords
artemisinic acid, artemisinin, cytochrome P450 monooxygenase, CYP71AV1, Artemisia annua, Saccharomyces cerevisiae, microbial production, mevalonate pathway, sesquiterpene lactone biosynthesis, malaria
MeSH terms
Animals, Antimalarials, Cytochrome P-450 Enzyme System, Fermentation, Genetic Engineering, Gas Chromatography-Mass Spectrometry, Mevalonic Acid, Molecular Sequence Data, Plasmodium falciparum, Saccharomyces cerevisiae, Sesquiterpenes, Drug Costs, Malaria, Falciparum, Bioreactors, Artemisia annua, Artemisinins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review